NCT06081296

Brief Summary

Objective: The objective is to evaluate the dimensional changes of soft tissue and alveolar ridge after extraction of posterior elements with different clinical protocols of alveolar preservation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

October 2, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 13, 2023

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2023

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

October 13, 2023

Status Verified

October 1, 2023

Enrollment Period

1.1 years

First QC Date

October 2, 2023

Last Update Submit

October 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • assessment of dimensional change using linear measurements through CT, evaluating bone remodeling.

    Through CT taken immediately after tooth extraction and six months later, these images will be analyzed to evaluate changes in hard tissues

    6 months

Secondary Outcomes (2)

  • evaluation of the dimensional change of soft tissues that accompany bone remodeling through linear and volume measurements in the STL

    6 months

  • Visual analogy scale for pain and disconfort evaluattion which consists of a score to measure the patient's pain intensity.

    1 week

Study Arms (4)

Control group

EXPERIMENTAL

Alveolus closure with total flap elevation and simple suture

Procedure: Control group

Group Free Gingival Mixed Graft

ACTIVE COMPARATOR

Closure of the alveolus without flap elevation, and placement of a mixed free gingival tissue graft (epithelialized in the central region and de-epithelialized (2 mm) in the vestibulolingual edges

Procedure: Mixed free gingival graft group

Bone + Mixed Free Gum Graft Group

ACTIVE COMPARATOR

Socket closure without flap elevation, placement of lyophilized bone graft and socket sealing with mixed free gingival tissue graft (as previously described)

Procedure: Bone+ mixed free gingival graft group

Bone + Titanium Seal Group

ACTIVE COMPARATOR

Socket closure without flap elevation, placement of lyophilized bone graft, socket sealing by installing a non-absorbable titanium membrane.

Procedure: Bone + Titanium Seal group

Interventions

Control groupPROCEDURE

Control Group (Ctl): alveolus closure with total flap elevation and simple suture; and socket sealing with mixed free gingival tissue graft.

Also known as: Mixed free gingival graft group, Bone+ mixed free gingival graft group, Bone + Titanium Seal group
Control group

closure of the alveolus without flap elevation, and placement of a free gingival tissue graft removed from the individual's own palate, which will be properly sutured. This graft is a combination of epithelialized-subepithelial connective tissue graft, which will be taken from the hard palate of the regions.

Also known as: Bone+ mixed free gingival graft group, Bone + Titanium Seal group
Group Free Gingival Mixed Graft

closure of the socket without flap elevation, placement of a freeze-dried bone graft and sealing of the socket with a mixed free gingival tissue graft.

Also known as: Bone + Titanium Seal group
Bone + Mixed Free Gum Graft Group

socket closure without flap elevation, placement of lyophilized bone graft, socket sealing by installing a non-absorbable titanium membrane.

Bone + Titanium Seal Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Systemic health (Hypertension and Diabetes controlled)
  • Indication of tooth extraction with at least 2/3 of the bone support, in the premolar or molar region
  • Signing the consent form
  • Individuals over 18 years of age.

You may not qualify if:

  • Presence of periodontal disease at the time of surgery
  • Pregnant and lactating women
  • Smokers
  • Being in orthodontic treatment
  • Use medication that alters the bone healing process, such as those used to treat osteoporosis and the bisphosphonate group
  • Individuals under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Piracicaba Dental School

Piracicaba, São Paulo, 13414903, Brazil

RECRUITING

Related Publications (1)

  • Sandoli Arroteia L, Lopes MP, Rea MT, Vieira E Oliveira TR, Oliveira ML, de Faveri M, Santamaria MP, Queiroz LA, Casati MZ, Casarin RCV. Dimensional Changes After Different Alveolar Ridge Preservation Techniques for Posterior Region: A Randomised Controlled Clinical Trial. J Clin Periodontol. 2025 Nov;52(11):1584-1594. doi: 10.1111/jcpe.70004. Epub 2025 Aug 5.

MeSH Terms

Conditions

Alveolar Bone Loss

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Renato Casarin, PhD

    University of Campinas, Brazil

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Renato Casarin, PhD

CONTACT

Leticia S Arroteia, DDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Randomization by electronically generated list; Different examiners than operator; Bliding patient;
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Randomized Clinical Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associated Professor

Study Record Dates

First Submitted

October 2, 2023

First Posted

October 13, 2023

Study Start

September 1, 2022

Primary Completion

October 15, 2023

Study Completion

September 1, 2024

Last Updated

October 13, 2023

Record last verified: 2023-10

Locations